FDA COVID-19 Diagnostic Test Fellowship

Organization
U.S. Food and Drug Administration (FDA)
Reference Code
FDA-CBER-2020-0052
How to Apply

Connect with ORISE...on the GO!  Download the new ORISE GO mobile app in the Apple or Google Play Store to help you stay engaged, connected, and informed during your ORISE experience and beyond!

A complete application consists of:      

All documents must be in English or include an official English translation.

If you have questions, send an email to ORISE.FDA.CBER@orau.org. Please include the reference code for this opportunity in your email.

Application Deadline
9/30/2020 3:00:00 PM Eastern Time Zone
Description

*Applications will be reviewed on a rolling-basis.

A research opportunity is currently available in the laboratory of Dr. Paul Carlson in the Office of Vaccine Research and Review (OVRR), at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) in Silver Spring, Maryland.

Since SARS-CoV-2 has been detected in the stool of both symptomatic and asymptomatic individuals, a better understanding of stool shedding and methods for testing for the virus in stool is vital to ensure the continued safety of Fecal Microbiota Transplantation (FMT) products. Under the guidance of a mentor, the selected participant will be involved in the development and validation of assays for testing stool for SARS-CoV-2, including qPCR, ddPCR, NGS, and CRISPR methodologies.  These methods will also be applied by the participant for development of diagnostic tests for malaria in collaboration with Dr. Heather Painter (FDA/CBER).

Anticipated Appointment Start Date: July 1, 2020

This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.

Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded at FDA.  OPM can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.

FDA requires ORISE participants to read and sign their FDA Education and Training Agreement within 30 days of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency.  This agreement covers such topics as the following:

  • Non-employee nature of the ORISE appointment;
  • Prohibition on ORISE Fellows performing inherently governmental functions;
  • Obligation of ORISE Fellows to convey all necessary rights to the FDA regarding intellectual property conceived or first reduced to practice during their fellowship;
  • The fact that research materials and laboratory notebooks are the property of the FDA;
  • ORISE fellow’s obligation to protect and not to further disclose or use non-public information.
Qualifications

The qualified candidate should be currently pursuing or have received a bachelor's, master's or doctoral degree in one of the relevant fields. Degree must have been received within five years of the appointment start date. 

Preferred skills:

  • Tissue culturing
  • RNA-sequencing
  • Proteomics
  • Bioinformatics (Python, R)
  • Strong written and oral communication skills
Eligibility Requirements
  • Citizenship: U.S. Citizen Only
  • Degree: Bachelor's Degree, Master's Degree, or Doctoral Degree received within the last 60 months or currently pursuing.
  • Discipline(s):
    • Life Health and Medical Sciences (9 )